Alfredo L. V.
- Country
- Spain
- Department
- Digestive
Research Overview
- Evaluation of EPI-EE in Eosinophilic Esophagitis: A Study on Tolerability, Toxicity, Pharmacokinetics, and Molecular Mechanisms of Action
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 125 of 296 partner sites.
Specializations
Hepatology Research
The investigator specializes in the study of nonalcoholic steatohepatitis (NASH), focusing on innovative therapeutic approaches for patients with precirrhotic conditions. Their research encompasses liver disease progression and novel treatment modalities.
- Precirrhotic NASH management
- Liver fibrosis assessment
- Metabolic liver disease
The research extends to evaluating therapeutic interventions that target NASH resolution while preventing fibrosis progression.
Gastroenterology Focus
A significant portion of the investigator's work centers on eosinophilic esophagitis (EoE), investigating both established and emerging treatments for this chronic inflammatory condition.
- Inflammatory esophageal disorders
- Tissue inflammation assessment
- Dysphagia treatment
Their research includes evaluation of various therapeutic approaches for managing EoE symptoms and inflammation.
Treatment Optimization
The investigator explores therapeutic delivery mechanisms and dosing strategies, particularly in the context of orodispersible medications for esophageal conditions.
- Drug delivery systems
- Treatment efficacy assessment
- Long-term tolerability studies
Research efforts include comparative analyses of different dosing regimens to optimize treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.